{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T10:24:17Z","timestamp":1784715857411,"version":"3.55.0"},"reference-count":144,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jare.2024.01.033","type":"journal-article","created":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T06:17:45Z","timestamp":1706854665000},"page":"121-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["The role of transcription factors in the crosstalk between cancer-associated fibroblasts and tumor cells"],"prefix":"10.1016","volume":"67","author":[{"given":"Xiaoyan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqi","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Midie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jare.2024.01.033_b0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov"},{"issue":"5","key":"10.1016\/j.jare.2024.01.033_b0010","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.jare.2024.01.033_b0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.jare.2024.01.033_b0020","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/annonc\/mdw168","article-title":"Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy","volume":"27","author":"Pitt","year":"2016","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.jare.2024.01.033_b0025","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12051232","article-title":"Communication in the cancer microenvironment as a target for therapeutic interventions","volume":"12","author":"Dominiak","year":"2020","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.jare.2024.01.033_b0030","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","article-title":"Clinical and therapeutic relevance of cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"10.1016\/j.jare.2024.01.033_b0035","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1152\/physrev.00048.2019","article-title":"Diversity and biology of cancer-associated fibroblasts","volume":"101","author":"Biffi","year":"2021","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jare.2024.01.033_b0040","doi-asserted-by":"crossref","unstructured":"M. Olivier, M. Hollstein, P. Hainaut, TP53 mutations in human cancers: origins, consequences, and clinical use, Cold Spring Harbor Perspect. Biol. (2010). doi:10.1101\/cshperspect.a001008.","DOI":"10.1101\/cshperspect.a001008"},{"issue":"1","key":"10.1016\/j.jare.2024.01.033_b0045","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41571-021-00549-2","article-title":"The MYC oncogene \u2014 the grand orchestrator of cancer growth and immune evasion","volume":"19","author":"Dhanasekaran","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"10.1016\/j.jare.2024.01.033_b0050","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s10555-020-09915-5","article-title":"Molecular epidemiology and diagnostics of KRAS mutations in human cancer","volume":"39","author":"Timar","year":"2020","journal-title":"Cancer Metastasis Rev"},{"issue":"5","key":"10.1016\/j.jare.2024.01.033_b0055","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/ng.117","article-title":"No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas","volume":"40","author":"Qiu","year":"2008","journal-title":"Nature Genet"},{"issue":"4","key":"10.1016\/j.jare.2024.01.033_b0060","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.cell.2018.01.029","article-title":"The human transcription factors","volume":"172","author":"Lambert","year":"2018","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.jare.2024.01.033_b0065","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrg2538","article-title":"A census of human transcription factors: function, expression and evolution","volume":"10","author":"Vaquerizas","year":"2009","journal-title":"Nat Rev Genet"},{"issue":"1","key":"10.1016\/j.jare.2024.01.033_b0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/cac2.12392","article-title":"Signaling pathways in cancer-associated fibroblasts: recent advances and future perspectives","volume":"43","author":"Fang","year":"2023","journal-title":"Cancer Commun"},{"issue":"1","key":"10.1016\/j.jare.2024.01.033_b0075","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-022-10312-0","article-title":"Multiplexed immunofluorescence analysis of CAF-markers, EZH2 and FOXM1 in gastric tissue: associations with clinicopathological parameters and clinical outcomes","volume":"22","author":"Sun","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jare.2024.01.033_b0080","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.semcancer.2019.08.004","article-title":"Cancer-associated fibroblasts in desmoplastic tumors: emerging role of integrins","volume":"62","author":"Zeltz","year":"2020","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"10.1016\/j.jare.2024.01.033_b0085","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol Rev"},{"issue":"15","key":"10.1016\/j.jare.2024.01.033_b0090","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1016\/j.ejca.2014.06.021","article-title":"Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies","volume":"50","author":"Haqq","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jare.2024.01.033_b0095","doi-asserted-by":"crossref","unstructured":"H. Kiaris, I. Chatzistamou, G. Trimis, M. Frangou-Plemmenou, A. Pafiti-Kondi, A. Kalofoutis, Evidence for nonautonomous effect of p53 tumor suppressor in carcinogenesis, Cancer Res. (2005). doi:10.1158\/0008-5472.CAN-04-3791.","DOI":"10.1158\/0008-5472.CAN-04-3791"},{"issue":"6","key":"10.1016\/j.jare.2024.01.033_b0100","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.molonc.2013.08.007","article-title":"c-Ski activates cancer-associated fibroblasts to regulate breast cancer cell invasion","volume":"7","author":"Wang","year":"2013","journal-title":"Mol Oncol"},{"key":"10.1016\/j.jare.2024.01.033_b0105","doi-asserted-by":"crossref","unstructured":"C. Weigel, M.A. Maczis, E.N.D. Palladino, C.D. Green, M. Maceyka, C. Guoet al., Sphingosine kinase 2 in stromal fibroblasts creates a hospitable tumor microenvironment in breast cancer, Cancer Res. (2023). doi:10.1158\/0008-5472.CAN-22-1638.","DOI":"10.1158\/0008-5472.22433478.v1"},{"key":"10.1016\/j.jare.2024.01.033_b0110","doi-asserted-by":"crossref","unstructured":"S. Ma, M.H. Mcguire, L.S. Mangala, S. Lee, E. Stur, W. Huet al., Gain-of-function p53 protein transferred via small extracellular vesicles promotes conversion of fibroblasts to a cancer-associated phenotype, Cell Reports (2021). doi:10.1016\/j.celrep.2021.108726.","DOI":"10.1016\/j.celrep.2021.108726"},{"issue":"5","key":"10.1016\/j.jare.2024.01.033_b0115","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/s41388-020-01576-6","article-title":"Merkel cell carcinoma-derived exosome-shuttle miR-375 induces fibroblast polarization by inhibition of RBPJ and p53","volume":"40","author":"Fan","year":"2021","journal-title":"Oncogene"},{"issue":"52","key":"10.1016\/j.jare.2024.01.033_b0120","doi-asserted-by":"crossref","first-page":"18691","DOI":"10.1073\/pnas.1412062112","article-title":"TSPAN12 is a critical factor for cancer\u2013fibroblast cell contact-mediated cancer invasion","volume":"111","author":"Otomo","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.jare.2024.01.033_b0125","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ccr.2009.12.041","article-title":"Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-\u03baB-dependent manner","volume":"17","author":"Erez","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jare.2024.01.033_b0130","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.canlet.2020.03.004","article-title":"Extracellular vesicle packaged LMP1-activated fibroblasts promote tumor progression via autophagy and stroma-tumor metabolism coupling","volume":"478","author":"Wu","year":"2020","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jare.2024.01.033_b0135","doi-asserted-by":"crossref","unstructured":"S. Hendrayani, B. Al-Harbi, M.M. Al-Ansari, G. Silva, A. Aboussekhra, The inflammatory\/cancer-related IL-6\/STAT3\/NF-\u03baB positive feedback loop includes AUF1 and maintains the active state of breast myofibroblasts, Oncotarget (2016). doi:10.18632\/oncotarget.9633.","DOI":"10.18632\/oncotarget.9633"},{"issue":"1","key":"10.1016\/j.jare.2024.01.033_b0140","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-021-00410-6","article-title":"PLAU directs conversion of fibroblasts to inflammatory cancer-associated fibroblasts, promoting esophageal squamous cell carcinoma progression via uPAR\/Akt\/NF-\u03baB\/IL8 pathway","volume":"7","author":"Fang","year":"2021","journal-title":"Cell Death Discovery"},{"issue":"1","key":"10.1016\/j.jare.2024.01.033_b0145","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-02583-0","article-title":"Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer","volume":"9","author":"Fang","year":"2018","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.jare.2024.01.033_b0150","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-021-03579-x","article-title":"The role of PKM2 nuclear translocation in the constant activation of the NF-\u03baB signaling pathway in cancer-associated fibroblasts","volume":"12","author":"Gu","year":"2021","journal-title":"Cell Death Dis"},{"issue":"3","key":"10.1016\/j.jare.2024.01.033_b0155","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202001430RR","article-title":"MicroRNA-370-3p shuttled by breast cancer cell-derived extracellular vesicles induces fibroblast activation through the CYLD\/Nf-\u03baB axis to promote breast cancer progression","volume":"35","author":"Ren","year":"2021","journal-title":"FASEB J"},{"issue":"3","key":"10.1016\/j.jare.2024.01.033_b0160","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s13238-013-2084-3","article-title":"NF-\u03baB and STAT3 signaling pathways collaboratively link inflammation to cancer","volume":"4","author":"Fan","year":"2013","journal-title":"Protein Cell"},{"key":"10.1016\/j.jare.2024.01.033_b0165","doi-asserted-by":"crossref","unstructured":"G. Biffi, T.E. Oni, B. Spielman, Y. Hao, E. Elyada, Y. Parket al., IL1-induced JAK\/STAT signaling is antagonized by TGF\u03b2 to shape CAF heterogeneity in pancreatic ductal adenocarcinoma, Cancer Discov. (2019). doi:10.1158\/2159-8290.CD-18-0710.","DOI":"10.1158\/2159-8290.CD-18-0710"},{"issue":"11","key":"10.1016\/j.jare.2024.01.033_b0170","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1002\/1878-0261.13053","article-title":"LAMC1 upregulation via TGF\u03b2 induces inflammatory cancer-associated fibroblasts in esophageal squamous cell carcinoma via NF-\u03baB\u2013CXCL1\u2013STAT3","volume":"15","author":"Fang","year":"2021","journal-title":"Mol Oncol"},{"issue":"4","key":"10.1016\/j.jare.2024.01.033_b0175","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.7150\/ijbs.69178","article-title":"TSG-6 promotes cancer cell aggressiveness in a CD44-dependent manner and reprograms normal fibroblasts to create a pro-metastatic microenvironment in colorectal cancer","volume":"18","author":"Liu","year":"2022","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.jare.2024.01.033_b0180","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.837781","article-title":"Mesenchymal stem cells derived from adipose tissue accelerate the progression of colon cancer by inducing a MTCAF phenotype via ICAM1\/STAT3\/AKT axis","volume":"12","author":"Xue","year":"2022","journal-title":"Front Oncol"},{"issue":"9","key":"10.1016\/j.jare.2024.01.033_b0185","doi-asserted-by":"crossref","DOI":"10.3390\/genes13091579","article-title":"Senescent fibroblasts generate a CAF phenotype through the STAT3 Pathway","volume":"13","author":"Li","year":"2022","journal-title":"Genes"},{"issue":"6","key":"10.1016\/j.jare.2024.01.033_b0190","doi-asserted-by":"crossref","DOI":"10.3390\/cells8060538","article-title":"Nodal facilitates differentiation of fibroblasts to cancer-associated fibroblasts that support tumor growth in melanoma and colorectal cancer","volume":"8","author":"Li","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jare.2024.01.033_b0195","doi-asserted-by":"crossref","unstructured":"K. Lee, S. Yeo, C.O. Sung, S. Kim, Twist1 Is a key regulator of cancer-associated fibroblasts, Cancer Res. (2015). doi:10.1158\/0008-5472.CAN-14-0350.","DOI":"10.1158\/0008-5472.CAN-14-0350"},{"issue":"12","key":"10.1016\/j.jare.2024.01.033_b0200","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.1111\/jcmm.16556","article-title":"HIF-1\u03b1 is necessary for activation and tumour-promotion effect of cancer-associated fibroblasts in lung cancer","volume":"25","author":"Zhang","year":"2021","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jare.2024.01.033_b0205","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-022-05320-8","article-title":"The role of cancer-associated fibroblasts in tumorigenesis of gastric cancer","author":"Sun","year":"2022","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jare.2024.01.033_b0210","doi-asserted-by":"crossref","unstructured":"J.M. Lee, S. Dedhar, R. Kalluri, E.W. Thompson, The epithelial\u2013mesenchymal transition: new insights in signaling, development, and disease, The Journal of Cell Biology (2006). doi:10.1083\/jcb.200601018.","DOI":"10.1083\/jcb.200601018"},{"issue":"7","key":"10.1016\/j.jare.2024.01.033_b0215","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/1878-0261.12080","article-title":"Epithelial-to-mesenchymal transition transcription factors in cancer-associated fibroblasts","volume":"11","author":"Baulida","year":"2017","journal-title":"Mol Oncol"},{"issue":"3","key":"10.1016\/j.jare.2024.01.033_b0220","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrm757","article-title":"The snail superfamily of zinc-finger transcription factors","volume":"3","author":"Nieto","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"12","key":"10.1016\/j.jare.2024.01.033_b0225","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1002\/ijc.28613","article-title":"Protumorigenic effects of Snail-expression fibroblasts on colon cancer cells","volume":"134","author":"Herrera","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jare.2024.01.033_b0230","doi-asserted-by":"crossref","unstructured":"J. Stanisavljevic, J. Loubat-Casanovas, M. Herrera, T. Luque, R. Pe\u00f1a, A. Lluchet al., Snail1-expressing fibroblasts in the tumor microenvironment display mechanical properties that support metastasis, Cancer Res. (2015). doi:10.1158\/0008-5472.CAN-14-1903.","DOI":"10.1158\/0008-5472.CAN-14-1903"},{"issue":"1","key":"10.1016\/j.jare.2024.01.033_b0235","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-11-350","article-title":"Twist and snai1 expression in pharyngeal squamous cell carcinoma stroma is related to cancer progression","volume":"11","author":"Jouppila-M\u00e4tt\u00f6","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jare.2024.01.033_b0240","article-title":"Transcription factor snail1 expression and poor survival in pharyngeal squamous cell carcinoma","author":"Jouppila-M\u00e4tt\u00f6","year":"2011","journal-title":"Histol Histopath"},{"issue":"2","key":"10.1016\/j.jare.2024.01.033_b0245","doi-asserted-by":"crossref","first-page":"874","DOI":"10.18632\/oncotarget.2716","article-title":"TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer","volume":"6","author":"Galv\u00e1n","year":"2015","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.jare.2024.01.033_b0250","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.ajpath.2011.06.032","article-title":"Twist1 is up-regulated in gastric cancer-associated fibroblasts with poor clinical outcomes","volume":"179","author":"Sung","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jare.2024.01.033_b0255","doi-asserted-by":"crossref","unstructured":"E.L. Spaeth, A.M. Labaff, B.P. Toole, A. Klopp, M. Andreeff, F.C. Marini, Mesenchymal CD44 expression contributes to the acquisition of an activated fibroblast phenotype via TWIST activation in the tumor Microenvironment, Cancer Res. (2013). doi:10.1158\/0008-5472.CAN-13-0087.","DOI":"10.1158\/0008-5472.CAN-13-0087"},{"issue":"11","key":"10.1016\/j.jare.2024.01.033_b0260","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1038\/s41388-021-01663-2","article-title":"Tumor-derived osteopontin drives the resident fibroblast to myofibroblast differentiation through Twist1 to promote breast cancer progression","volume":"40","author":"Butti","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.jare.2024.01.033_b0265","doi-asserted-by":"crossref","unstructured":"J. Caramel, M. Ligier, A. Puisieux, Pleiotropic roles for ZEB1 in cancer, Cancer Res. (2018). doi:10.1158\/0008-5472.CAN-17-2476.","DOI":"10.1158\/0008-5472.CAN-17-2476"},{"issue":"1","key":"10.1016\/j.jare.2024.01.033_b0270","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.surg.2014.02.018","article-title":"Prognostic significance of Zinc finger E-box binding homeobox 1 (ZEB1) expression in cancer cells and cancer-associated fibroblasts in pancreatic head cancer","volume":"156","author":"Bronsert","year":"2014","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.jare.2024.01.033_b0275","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1002\/hep.32069","article-title":"Zinc finger E-box binding homeobox 1 promotes cholangiocarcinoma progression through tumor dedifferentiation and tumor\u2013stroma paracrine signaling","volume":"74","author":"Lobe","year":"2021","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jare.2024.01.033_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109009","article-title":"Contextual cues from cancer cells govern cancer-associated fibroblast heterogeneity","volume":"35","author":"Bota-Rabassedas","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.jare.2024.01.033_b0285","doi-asserted-by":"crossref","unstructured":"Y. Du, Q. Long, L. Zhang, Y. Shi, X. Liu, X. Liet al., Curcumin inhibits cancer-associated fibroblast-driven prostate cancer invasion through MAOA\/mTOR\/HIF-1\u03b1 signaling, Int. J. Oncol. (2015). doi:10.3892\/ijo.2015.3202.","DOI":"10.3892\/ijo.2015.3202"},{"issue":"17","key":"10.1016\/j.jare.2024.01.033_b0290","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1038\/onc.2016.404","article-title":"Serglycin in tumor microenvironment promotes non-small cell lung cancer aggressiveness in a CD44-dependent manner","volume":"36","author":"Guo","year":"2017","journal-title":"Oncogene"},{"issue":"14","key":"10.1016\/j.jare.2024.01.033_b0295","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.7150\/ijbs.45446","article-title":"Cancer-associated fibroblasts induce epithelial-mesenchymal transition via the transglutaminase 2-dependent IL-6\/IL6R\/STAT3 axis in hepatocellular carcinoma","volume":"16","author":"Jia","year":"2020","journal-title":"Int J Biol Sci"},{"issue":"56","key":"10.1016\/j.jare.2024.01.033_b0300","doi-asserted-by":"crossref","first-page":"96035","DOI":"10.18632\/oncotarget.21635","article-title":"TGF\u03b21 in fibroblasts-derived exosomes promotes epithelial-mesenchymal transition of ovarian cancer cells","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.jare.2024.01.033_b0305","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1111\/cas.13991","article-title":"Heat shock factor 1 in cancer-associated fibroblasts is a potential prognostic factor and drives progression of oral squamous cell carcinoma","volume":"110","author":"Wang","year":"2019","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jare.2024.01.033_b0310","doi-asserted-by":"crossref","unstructured":"T. Yeung, C.S. Leung, K. Wong, G. Samimi, M.S. Thompson, J. Liuet al., TGF-\u03b2 modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment, Cancer Res. (2013). doi:10.1158\/0008-5472.CAN-13-0023.","DOI":"10.1158\/0008-5472.CAN-13-0023"},{"issue":"9","key":"10.1016\/j.jare.2024.01.033_b0315","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-018-0922-1","article-title":"HGF-mediated crosstalk between cancer-associated fibroblasts and MET-unamplified gastric cancer cells activates coordinated tumorigenesis and metastasis","volume":"9","author":"Ding","year":"2018","journal-title":"Cell Death Dis"},{"issue":"15-16","key":"10.1016\/j.jare.2024.01.033_b0320","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1101\/gad.347344.120","article-title":"miR-200 deficiency promotes lung cancer metastasis by activating Notch signaling in cancer-associated fibroblasts","volume":"35","author":"Xue","year":"2021","journal-title":"Genes Dev"},{"issue":"5","key":"10.1016\/j.jare.2024.01.033_b0325","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-022-04935-1","article-title":"Cancer associated fibroblast\u2013derived CCL5 promotes hepatocellular carcinoma metastasis through activating HIF1\u03b1\/ZEB1 axis","volume":"13","author":"Xu","year":"2022","journal-title":"Cell Death Dis"},{"issue":"4","key":"10.1016\/j.jare.2024.01.033_b0330","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1593\/neo.121228","article-title":"Interleukin-1\u03b2 promotes ovarian tumorigenesis through a p53\/NF-\u03baB-mediated inflammatory response in stromal fibroblasts","volume":"15","author":"Schauer","year":"2013","journal-title":"Neoplasia"},{"issue":"4","key":"10.1016\/j.jare.2024.01.033_b0335","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/bjc.2014.336","article-title":"IL-22 produced by cancer-associated fibroblasts promotes gastric cancer cell invasion via STAT3 and ERK signaling","volume":"111","author":"Fukui","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jare.2024.01.033_b0340","article-title":"Cancer-associated fibroblasts promote stem cell-like properties of hepatocellularcarcinoma cells through IL-6\/STAT3\/Notch signaling","author":"Xiong","year":"2018","journal-title":"Am J Cancer Res"},{"issue":"1","key":"10.1016\/j.jare.2024.01.033_b0345","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-018-0648-7","article-title":"Emerging roles of long non-coding RNAs in tumor metabolism","volume":"11","author":"Sun","year":"2018","journal-title":"J Hematol Oncol"},{"issue":"17","key":"10.1016\/j.jare.2024.01.033_b0350","doi-asserted-by":"crossref","first-page":"8322","DOI":"10.7150\/thno.62378","article-title":"Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming","volume":"11","author":"Li","year":"2021","journal-title":"Theranostics"},{"issue":"9","key":"10.1016\/j.jare.2024.01.033_b0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107701","article-title":"Epigenetic reprogramming of cancer-associated fibroblasts deregulates glucose metabolism and facilitates progression of breast cancer","volume":"31","author":"Becker","year":"2020","journal-title":"Cell Rep"},{"issue":"8","key":"10.1016\/j.jare.2024.01.033_b0360","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.celrep.2015.02.006","article-title":"Metabolic reprogramming of cancer-associated fibroblasts by IDH3\u03b1 downregulation","volume":"10","author":"Zhang","year":"2015","journal-title":"Cell Rep"},{"issue":"5","key":"10.1016\/j.jare.2024.01.033_b0365","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s41556-018-0096-1","article-title":"MYC sets a tumour-stroma metabolic loop","volume":"20","author":"Coller","year":"2018","journal-title":"Nat Cell Biol"},{"issue":"8","key":"10.1016\/j.jare.2024.01.033_b0370","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/s43018-022-00426-6","article-title":"Cancer-associated fibroblasts employ NUFIP1-dependent autophagy to secrete nucleosides and support pancreatic tumor growth","volume":"3","author":"Yuan","year":"2022","journal-title":"Nat Cancer"},{"issue":"5","key":"10.1016\/j.jare.2024.01.033_b0375","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41556-018-0083-6","article-title":"Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells","volume":"20","author":"Yan","year":"2018","journal-title":"Nat Cell Biol"},{"issue":"18","key":"10.1016\/j.jare.2024.01.033_b0380","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.4161\/cc.21701","article-title":"Metabolic remodeling of the tumor microenvironment: migration stimulating factor (MSF) reprograms myofibroblasts toward lactate production, fueling anabolic tumor growth","volume":"11","author":"Carito","year":"2012","journal-title":"Cell Cycle"},{"issue":"1","key":"10.1016\/j.jare.2024.01.033_b0385","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-022-01359-4","article-title":"Cancer-associated fibroblast-specific lncRNA LINC01614 enhances glutamine uptake in lung adenocarcinoma","volume":"15","author":"Liu","year":"2022","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jare.2024.01.033_b0390","doi-asserted-by":"crossref","unstructured":"D.C. Hinshaw, L.A. Shevde, The tumor microenvironment innately modulates cancer progression, Cancer Res. (2019). doi:10.1158\/0008-5472.CAN-18-3962.","DOI":"10.1158\/0008-5472.CAN-18-3962"},{"issue":"6","key":"10.1016\/j.jare.2024.01.033_b0395","first-page":"1763","article-title":"Comprehensive analysis of immune subtypes reveals the prognostic value of cytotoxicity and FAP+ fibroblasts in stomach adenocarcinoma, Cancer Immunology","volume":"72","author":"Wang","year":"2023","journal-title":"Immunotherapy"},{"issue":"2","key":"10.1016\/j.jare.2024.01.033_b0400","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00018-020-03517-8","article-title":"Melanoma-associated fibroblasts impair CD8+ T cell function and modify expression of immune checkpoint regulators via increased arginase activity","volume":"78","author":"\u00c9rsek","year":"2021","journal-title":"Cell Mol Life Sci"},{"issue":"9","key":"10.1016\/j.jare.2024.01.033_b0405","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1111\/cas.14135","article-title":"Cancer-associated fibroblast-derived interleukin-1\u03b2 activates protumor C-C motif chemokine ligand 22 signaling in head and neck cancer","volume":"110","author":"Huang","year":"2019","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jare.2024.01.033_b0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216095","article-title":"PLA2G2A+ cancer-associated fibroblasts mediate pancreatic cancer immune escape via impeding antitumor immune response of CD8+ cytotoxic T cells","volume":"558","author":"Ge","year":"2023","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jare.2024.01.033_b0415","doi-asserted-by":"crossref","unstructured":"T.A. Mace, Z. Ameen, A. Collins, S. Wojcik, M. Mair, G.S. Younget al., Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent manner, Cancer Res. (2013). doi:10.1158\/0008-5472.CAN-12-4601.","DOI":"10.1158\/0008-5472.CAN-12-4601"},{"key":"10.1016\/j.jare.2024.01.033_b0420","doi-asserted-by":"crossref","unstructured":"X. Yang, Y. Lin, Y. Shi, B. Li, W. Liu, W. Yinet al., FAP promotes immunosuppression by cancer-associated fibroblasts in the tumor microenvironment via STAT3\u2013CCL2 signaling, Cancer Res. (2016). doi:10.1158\/0008-5472.CAN-15-2973.","DOI":"10.1158\/0008-5472.CAN-15-2973"},{"key":"10.1016\/j.jare.2024.01.033_b0425","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.canlet.2021.06.009","article-title":"Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6\/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell carcinoma","volume":"518","author":"Zhao","year":"2021","journal-title":"Cancer Lett"},{"issue":"4","key":"10.1016\/j.jare.2024.01.033_b0430","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-018-0458-4","article-title":"Cancer-associated fibroblasts induce PDL1+ neutrophils through the IL6-STAT3 pathway that foster immune suppression in hepatocellular carcinoma","volume":"9","author":"Cheng","year":"2018","journal-title":"Cell Death Dis"},{"issue":"2","key":"10.1016\/j.jare.2024.01.033_b0435","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/gutjnl-2020-322924","article-title":"Targeting cancer-associated fibroblast-secreted WNT2 restores dendritic cell-mediated antitumour immunity","volume":"71","author":"Huang","year":"2022","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.jare.2024.01.033_b0440","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.neo.2016.09.003","article-title":"Tissue transglutaminase activates cancer-associated fibroblasts and contributes to gemcitabine resistance in pancreatic cancer","volume":"18","author":"Lee","year":"2016","journal-title":"Neoplasia"},{"key":"10.1016\/j.jare.2024.01.033_b0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.matbio.2022.11.005","article-title":"Calponin 1 increases cancer-associated fibroblasts-mediated matrix stiffness topromote chemoresistance in gastric cancer","volume":"115","author":"Lu","year":"2023","journal-title":"Matrix Biol"},{"key":"10.1016\/j.jare.2024.01.033_b0450","doi-asserted-by":"crossref","unstructured":"X. Chen, J. Zhao, T. Herjan, L. Hong, Y. Liao, C. Liuet al., IL-17\u2013induced HIF1\u03b1 drives resistance to anti\u2013PD-L1 via fibroblast-mediated immune exclusion, J. Exp. Med. (2022). doi:10.1084\/jem.20210693.","DOI":"10.1084\/jem.20210693"},{"key":"10.1016\/j.jare.2024.01.033_b0455","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.canlet.2019.04.002","article-title":"Cancer-associated fibroblasts-derived IL-8 mediates resistance to cisplatin in human gastric cancer","volume":"454","author":"Zhai","year":"2019","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.jare.2024.01.033_b0460","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41401-022-00927-1","article-title":"Calcipotriol abrogates cancer-associated fibroblast-derived IL-8-mediated oxaliplatin resistance in gastric cancer cells via blocking PI3K\/Akt signaling","volume":"44","author":"Zhao","year":"2023","journal-title":"Acta Pharmacol Sin"},{"issue":"16","key":"10.1016\/j.jare.2024.01.033_b0465","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1038\/s41388-022-02253-6","article-title":"Cancer-associated fibroblast-induced lncRNA UPK1A-AS1 confers platinum resistance in pancreatic cancer via efficient double-strand break repair","volume":"41","author":"Zhang","year":"2022","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.jare.2024.01.033_b0470","article-title":"Cancer-associated fibroblasts promote the survival of irradiated nasopharyngeal carcinoma cells via the NF-\u03baB pathway","volume":"40","author":"Huang","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"issue":"26","key":"10.1016\/j.jare.2024.01.033_b0475","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1801348115","article-title":"Hypoxic tumor microenvironment activates GLI2 via HIF-1\u03b1 and TGF-\u03b22 to promote chemoresistance in colorectal cancer","volume":"115","author":"Tang","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.jare.2024.01.033_b0480","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-022-01501-3","article-title":"circFARP1 enables cancer-associated fibroblasts to promote gemcitabine resistance in pancreatic cancer via the LIF\/STAT3 axis","volume":"21","author":"Hu","year":"2022","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/j.jare.2024.01.033_b0485","doi-asserted-by":"crossref","DOI":"10.1038\/srep38408","article-title":"Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11\/IL-11R\/STAT3 signaling pathway","volume":"6","author":"Tao","year":"2016","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.jare.2024.01.033_b0490","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1080\/21655979.2022.2032972","article-title":"Cancer-associated fibroblast exosomes promote chemoresistance to cisplatin in hepatocellular carcinoma through circZFR targeting signal transducers and activators of transcription (STAT3)\/nuclear factor -kappa B (NF-\u03baB) pathway","volume":"13","author":"Zhou","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.jare.2024.01.033_b0495","doi-asserted-by":"crossref","unstructured":"J. New, L. Arnold, M. Ananth, S. Alvi, M. Thornton, L. Werneret al., Secretory autophagy in cancer-associated fibroblasts promotes head and neck cancer progression and offers a novel therapeutic target, Cancer Res. (2017). doi:10.1158\/0008-5472.CAN-17-1077.","DOI":"10.1158\/0008-5472.CAN-17-1077"},{"issue":"6","key":"10.1016\/j.jare.2024.01.033_b0500","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.cmet.2018.08.006","article-title":"Increased lactate secretion by cancer cells sustains non-cell-autonomous adaptive resistance to MET and EGFR targeted therapies","volume":"28","author":"Apicella","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.jare.2024.01.033_b0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102076","article-title":"The cross-talk between tumor cells and activated fibroblasts mediated by lactate\/BDNF\/TrkB signaling promotes acquired resistance to anlotinib in human gastric cancer","volume":"46","author":"Jin","year":"2021","journal-title":"Redox Biol"},{"key":"10.1016\/j.jare.2024.01.033_b0510","doi-asserted-by":"crossref","DOI":"10.1111\/joim.12019","article-title":"VEGFA and tumour angiogenesis","author":"Claesson-Welsh","year":"2013","journal-title":"J Intern Med"},{"issue":"10","key":"10.1016\/j.jare.2024.01.033_b0515","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.7150\/thno.55074","article-title":"FOSL2 promotes VEGF-independent angiogenesis by transcriptionnally activating Wnt5a in breast cancer-associated fibroblasts","volume":"11","author":"Wan","year":"2021","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.jare.2024.01.033_b0520","doi-asserted-by":"crossref","DOI":"10.1186\/bcr3458","article-title":"HIF-1\u03b1\/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs)","volume":"15","author":"De Francesco","year":"2013","journal-title":"Breast Cancer Res"},{"issue":"16","key":"10.1016\/j.jare.2024.01.033_b0525","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.7150\/thno.18990","article-title":"MiR-205\/YAP1 in activated fibroblasts of breast tumor promotes VEGF-independent angiogenesis through STAT3 signaling","volume":"7","author":"Du","year":"2017","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.jare.2024.01.033_b0530","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","article-title":"Turning foes to friends: targeting cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2019","journal-title":"Nat Rev Drug Discov"},{"issue":"23","key":"10.1016\/j.jare.2024.01.033_b0535","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1182\/blood.2019003976","article-title":"Lessons to learn from tumor-educated platelets","volume":"137","author":"Roweth","year":"2021","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jare.2024.01.033_b0540","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.cell.2018.02.061","article-title":"Tumor-induced generation of splenic erythroblast-like Ter-cells promotes tumor progression","volume":"173","author":"Han","year":"2018","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.jare.2024.01.033_b0545","article-title":"Pancreatic cancer cells render tumor-associated macrophages metabolically reprogrammed by a GARP and DNA methylation-mediated mechanism","volume":"6","author":"Zhang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jare.2024.01.033_b0550","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.molimm.2022.04.011","article-title":"Inhibition of TFEB promotes tumor-educated dendritic cells activation to enhance antitumor immune responses","volume":"147","author":"Ding","year":"2022","journal-title":"Mol Immunol"},{"issue":"2","key":"10.1016\/j.jare.2024.01.033_b0555","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41591-018-0309-y","article-title":"Tumor-educated B cells selectively promote breast cancer lymph node metastasis by HSPA4-targeting IgG","volume":"25","author":"Gu","year":"2019","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.jare.2024.01.033_b0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110447","article-title":"Tumor-educated Tregs drive organ-specific metastasis in breast cancer by impairing NK cells in the lymph node niche","volume":"38","author":"Kos","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.jare.2024.01.033_b0565","doi-asserted-by":"crossref","unstructured":"L. Singh, E.S. Muise, A. Bhattacharya, J. Grein, S. Javaid, P. Stiverset al., ILT3 (LILRB4) promotes the immunosuppressive function of tumor-educated human monocytic myeloid-derived suppressor cells, Mol. Cancer Res. (2021). doi:10.1158\/1541-7786.MCR-20-0622.","DOI":"10.1158\/1541-7786.MCR-20-0622"},{"issue":"1","key":"10.1016\/j.jare.2024.01.033_b0570","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-020-01611-0","article-title":"Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways","volume":"39","author":"Yoshida","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"issue":"10","key":"10.1016\/j.jare.2024.01.033_b0575","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/carcin\/bgw085","article-title":"p53 functional deficiency in human colon cancer cells promotes fibroblast-mediated angiogenesis and tumor growth","volume":"37","author":"Hayashi","year":"2016","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.jare.2024.01.033_b0580","article-title":"Cancer cell-secreted IGF2 instigates fibroblasts and bone marrow-derived vascular progenitor cells to promote cancer progression","volume":"8","author":"Xu","year":"2017","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.jare.2024.01.033_b0585","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-022-01569-x","article-title":"Targeting TGF-\u03b2 signal transduction for fibrosis and cancer therapy","volume":"21","author":"Peng","year":"2022","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/j.jare.2024.01.033_b0590","article-title":"Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer","volume":"6","author":"Wu","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"10.1016\/j.jare.2024.01.033_b0595","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1002\/med.21886","article-title":"Targeting key proteins involved in transcriptional regulation for cancer therapy: current strategies and future prospective","volume":"42","author":"Pei","year":"2022","journal-title":"Med Res Rev"},{"issue":"4","key":"10.1016\/j.jare.2024.01.033_b0600","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ccell.2018.07.009","article-title":"Notch signaling in the tumor microenvironment","volume":"34","author":"Meurette","year":"2018","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.jare.2024.01.033_b0605","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.trecan.2020.11.007","article-title":"Targeting nuclear receptors for cancer therapy: premises, promises, and challenges","volume":"7","author":"Yang","year":"2021","journal-title":"Trends Cancer"},{"issue":"7","key":"10.1016\/j.jare.2024.01.033_b0610","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41574-020-0349-5","article-title":"Nuclear receptor crosstalk \u2014 defining the mechanisms for therapeutic innovation","volume":"16","author":"De Bosscher","year":"2020","journal-title":"Nat Rev Endocrinol"},{"issue":"9","key":"10.1016\/j.jare.2024.01.033_b0615","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.chembiol.2014.09.001","article-title":"Small-molecule inhibitors of protein-protein interactions: progressing toward the reality","volume":"21","author":"Arkin","year":"2014","journal-title":"Chem Biol"},{"issue":"9","key":"10.1016\/j.jare.2024.01.033_b0620","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41573-021-00199-0","article-title":"Advances in targeting \u2018undruggable\u2019 transcription factors with small molecules","volume":"20","author":"Henley","year":"2021","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"10.1016\/j.jare.2024.01.033_b0625","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1038\/s41401-021-00852-9","article-title":"Current strategies and progress for targeting the \u201cundruggable\u201d transcription factors","volume":"43","author":"Zhuang","year":"2022","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"10.1016\/j.jare.2024.01.033_b0630","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1210\/er.2002-0032","article-title":"Androgen receptor in prostate cancer","volume":"25","author":"Heinlein","year":"2004","journal-title":"Endocr Rev"},{"issue":"13","key":"10.1016\/j.jare.2024.01.033_b0635","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1056\/NEJMoa1207506","article-title":"Increased survival with enzalutamide in prostate cancer after chemotherapy","volume":"367","author":"Cabot","year":"2012","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.jare.2024.01.033_b0640","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1056\/NEJMoa2103425","article-title":"Belzutifan for renal cell carcinoma in von Hippel-Lindau disease","volume":"385","author":"Jonasch","year":"2021","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jare.2024.01.033_b0645","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: the past is prologue","volume":"21","author":"B\u00e9k\u00e9s","year":"2022","journal-title":"Nat Rev Drug Discov"},{"issue":"18","key":"10.1016\/j.jare.2024.01.033_b0650","doi-asserted-by":"crossref","first-page":"13487","DOI":"10.1021\/acs.jmedchem.1c00900","article-title":"Discovery of ARD-2585 as an exceptionally potent and orally active PROTAC degrader of androgen receptor for the treatment of advanced prostate cancer","volume":"64","author":"Xiang","year":"2021","journal-title":"J Med Chem"},{"issue":"22","key":"10.1016\/j.jare.2024.01.033_b0655","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.2174\/0929867328666211110101018","article-title":"Overview of PROTACs targeting the estrogen receptor: achievements for biologicaland drug discovery","volume":"29","author":"Qin","year":"2022","journal-title":"Curr Med Chem"},{"issue":"2","key":"10.1016\/j.jare.2024.01.033_b0660","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrc3430","article-title":"MDM2, MDMX and p53 in oncogenesis and cancer therapy","volume":"13","author":"Wade","year":"2013","journal-title":"Nat Rev Cancer"},{"issue":"6630","key":"10.1016\/j.jare.2024.01.033_b0665","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/387296a0","article-title":"Mdm2 promotes the rapid degradation of p53","volume":"387","author":"Haupt","year":"1997","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jare.2024.01.033_b0670","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-022-01314-3","article-title":"Targeting p53\u2013MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials","volume":"15","author":"Zhu","year":"2022","journal-title":"J Hematol Oncol"},{"issue":"15","key":"10.1016\/j.jare.2024.01.033_b0675","doi-asserted-by":"crossref","first-page":"10621","DOI":"10.1021\/acs.jmedchem.1c00940","article-title":"Recent progress and clinical development of inhibitors that block MDM4\/p53 protein\u2013protein interactions","volume":"64","author":"Zhang","year":"2021","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.jare.2024.01.033_b0680","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-018-0915-9","article-title":"BRD4 and Cancer: going beyond transcriptional regulation","volume":"17","author":"Donati","year":"2018","journal-title":"Mol Cancer"},{"issue":"6390","key":"10.1016\/j.jare.2024.01.033_b0685","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1126\/science.aao2793","article-title":"SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis","volume":"360","author":"Muhar","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jare.2024.01.033_b0690","doi-asserted-by":"crossref","unstructured":"M.H. Bui, X. Lin, D.H. Albert, L. Li, L.T. Lam, E.J. Faivreet al., Preclinical characterization of BET family bromodomain inhibitor ABBV-075 suggests combination therapeutic strategies, Cancer Res. (2017). doi:10.1158\/0008-5472.CAN-16-1793.","DOI":"10.1158\/0008-5472.CAN-16-1793"},{"issue":"7","key":"10.1016\/j.jare.2024.01.033_b0695","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1056\/NEJMoa1608345","article-title":"Reyes Gonzaga et al., Baricitinib versus placebo or adalimumab in rheumatoid arthritis","volume":"376","author":"Taylor","year":"2017","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.jare.2024.01.033_b0700","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1056\/NEJMoa1110556","article-title":"JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis","volume":"366","author":"Harrison","year":"2012","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jare.2024.01.033_b0705","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23061479","article-title":"Targeting transcription factors for cancer treatment","volume":"23","author":"Lambert","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.jare.2024.01.033_b0710","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-023-02934-4","article-title":"Transcription factors in fibroblast plasticity and CAF heterogeneity","author":"Melchionna","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.jare.2024.01.033_b0715","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2164-15-534","article-title":"Identification of cis-regulatory modules encoding temporal dynamics during development","author":"Potier","year":"2014","journal-title":"BMC Genomics"},{"issue":"6","key":"10.1016\/j.jare.2024.01.033_b0720","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1053\/j.gastro.2022.07.076","article-title":"Combined MEK and STAT3 inhibition uncovers stromal plasticity by enriching for cancer-associated fibroblasts with mesenchymal stem cell-like features to overcome immunotherapy resistance in pancreatic cancer","volume":"163","author":"Datta","year":"2022","journal-title":"Gastroenterology"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123224000468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123224000468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:50:36Z","timestamp":1734396636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123224000468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":144,"alternative-id":["S2090123224000468"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2024.01.033","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of transcription factors in the crosstalk between cancer-associated fibroblasts and tumor cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2024.01.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Production and hosting by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}